(19)
(11) EP 3 469 089 A1

(12)

(43) Date of publication:
17.04.2019 Bulletin 2019/16

(21) Application number: 17810911.2

(22) Date of filing: 07.06.2017
(51) International Patent Classification (IPC): 
C12P 19/04(2006.01)
A23L 33/10(2016.01)
 C08B 37/00(2006.01)
A23L 33/125(2016.01)
(86) International application number:
PCT/US2017/036270
(87) International publication number:
WO 2017/214224 (14.12.2017 Gazette 2017/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 09.06.2016 US 201615177368
09.06.2016 US 201615177376
09.06.2016 US 201615177383

(71) Applicant: F3 Platform Biologics, Inc.
Atlanta, GA 30338 (US)

(72) Inventors:
  • COX, Brad
    Fishers, Indiana 46040 (US)
  • JAMROG, Derek
    Indianapolis, Indiana 46220 (US)
  • ZURCHER, Kip
    Carmel, Indiana 46033 (US)

(74) Representative: Ferreccio, Rinaldo 
Botti & Ferrari S.r.l. Via Cappellini, 11
20124 Milano
20124 Milano (IT)

   


(54) EUGLENA LYSATE COMPOSITION AND METHOD FOR PRODUCING THE COMPOSITION AND A PURIFIED BETA-1,3-GLUCAN